Screener
LeMaitre Vascular LMAT Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by LeMaitre Vascular in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The source filing: LeMaitre Vascular’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333762
| Line item | For the six months ended / June 30, 2026 | For the six months ended / June 30, 2025 |
|---|---|---|
| Deferred payments for acquisitions | (95) | (1,433) |
| Payment of withholding taxes in connection with net settlement of equity awards | (477) | (605) |
| Common stock cash dividend paid | (11,427) | (9,037) |
| Net cash used in financing activities | (8,271) | (8,003) |
| Effect of exchange rate changes on cash and cash equivalents | (207) | 909 |
| Net (decrease) increase in cash and cash equivalents | (1,619) | 1,567 |
| Cash and cash equivalents at beginning of period | 28,244 | 25,610 |
| Cash and cash equivalents at end of period | $26,625 | $27,177 |
Item 1. Financial Statements
FAQ
- What is LeMaitre Vascular's financing cash flow?
- LeMaitre Vascular (LMAT) reported financing cash flow of -$5.05M in Q2 2026.
- How has LeMaitre Vascular's financing cash flow changed year-over-year?
- LeMaitre Vascular's financing cash flow decreased by 82.8% year-over-year, from -$2.76M to -$5.05M.
- What is the long-term trend for LeMaitre Vascular's financing cash flow?
- Over 3 years (2022 to 2025), LeMaitre Vascular's financing cash flow has grown at a 16.3% compound annual growth rate (CAGR), from -$9.23M to -$14.54M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.
Ask your AI about LeMaitre Vascular's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude